| Particulars |
| Company Name |
Cohance Lifesciences Ltd |
| Face Value |
1 |
| BSE Code |
543064 |
| Year End |
202503 |
| Full Year |
| Equity (Rs in Cr.) |
38.26 |
| B.V. Rs |
60.90 |
| Sales Rs in Cr. |
1,093.51 |
| NP Rs in Cr. |
271.71 |
| NP Var% |
0.00 |
| Div% |
0.00 |
| CPS Rs |
8.60 |
| EPS Rs |
7.10 |
| Traded Value(Rs in Lakhs) |
59.90 |
| 52 Week High |
1,359.00 |
| 52 Week Low |
922.00 |
| Price BSE |
980.00 |
| Price NSE |
979.00 |
| Market Capital(Rs in Cr.) |
37,506.88 |
| P/C Ratio |
114.00 |
| P/E Ratio |
138.00 |
| Price Vs.BV |
16.09 |
| Latest Quarter |
| Year End |
202503 |
| Sales Rs in Cr. |
330.17 |
| NP Rs in Cr. |
44.34 |
| NP Var % |
-17.00 |
| Trailing Twelve Months |
| Year End |
202503 |
| Sales |
914.50 |
| OPM |
35.57 |
| NP |
247.20 |
| NP Var% |
-0.21 |
| EPS |
7.10 |
| PE |
138.08 |
|